Vyxeos
FDA Approves Vyxeos for 2 Types of AML
The FDA approved Vyxeos, Jazz Pharmaceuticals)to treat adults with two types of acute myeloid leukemia (AML): newly ...
AUGUST 4, 2017
Vyxeos Increases Survival in High-Risk AML
Experimental treatment reduced the risk for death by 31% for older patients with secondary acute myeloid leukemia.
MARCH 28, 2016
Load more